St. John's wort, feverfew U.S. Pharmacopeia "informational" monographs released.
This article was originally published in The Tan Sheet
Executive Summary
ST. JOHN's WORT USP "INFORMATIONAL" MONOGRAPH for health professionals and consumers recommends against use of the botanical derived from hypericum when taking monoamine oxidase (MAO) inhibitors, selective serotonin reuptake inhibitors or other medications for depression. Released Aug. 10, the U.S. Pharmacopeia monograph notes that while "no drug interactions have been reported" and "it has not been reported specifically in the literature, hypericum has the potential to interact with MAO inhibitors and selective serotonin reuptake inhibitors."